Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV specialist ViiV Healthcare in a deal that ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...

Pfizer (PFE) stock is in focus as the company exits GSK (GSK)-owned ViiV Healthcare as Shionogi increases its stake to 21.7% ...

Key takeaways from Supreme Court arguments on Nov. 5 over the legality of the Trump administration’s reciprocal and fentanyl-linked tariffs led Bloomberg Intelligence’s Votes and Verdicts podcast this ...

(Bloomberg) -- A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s ...

On July 30, 2025, the U.S. District Court for the District of Delaware entered a Final Judgment in the dispute between Alnylam Pharmaceuticals, Inc. (“Alnylam”) and Pfizer, Inc. (“Pfizer”)—concluding ...

Orient Pharma was hit with a patent infringement lawsuit on June 16 in Delaware District Court over its attempt to market generic versions of Pfizer's Xeljanz XR treatment for autoimmune conditions.